257 related articles for article (PubMed ID: 393645)
1. Clinical aspects of the treatment of obesity by drugs: a review.
Munro JF
Int J Obes; 1979; 3(2):171-80. PubMed ID: 393645
[TBL] [Abstract][Full Text] [Related]
2. Dental considerations of patients taking appetite suppressants.
Wynn RL
Gen Dent; 1997; 45(4):324-8, 330-1. PubMed ID: 9515435
[No Abstract] [Full Text] [Related]
3. Clinical use of appetite suppressants.
Silverstone T
Drug Alcohol Depend; 1986 Jun; 17(2-3):151-67. PubMed ID: 3527636
[No Abstract] [Full Text] [Related]
4. Severe heart valve disease on appetite suppressants.
Prescrire Int; 1998 Feb; 7(33):19-20. PubMed ID: 10183395
[No Abstract] [Full Text] [Related]
5. Obesity.
Arterburn D
Clin Evid; 2003 Dec; (10):676-89. PubMed ID: 15555115
[No Abstract] [Full Text] [Related]
6. Treatment of obesity. Appetite suppressant drugs and intestinal by-pass surgery.
Bleehen SS; Edwards IR; Clark RG
Br J Dermatol; 1976 Aug; 95(2):219-222. PubMed ID: 782507
[No Abstract] [Full Text] [Related]
7. A comparative trial of fenfluramine and diethylpropion inbesity.
Silverstone JT; Cooper RM; Begg RR
Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
[No Abstract] [Full Text] [Related]
8. [Drug-clinics. The hue and cry over central appetite suppressants!].
Scheen AJ
Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348
[No Abstract] [Full Text] [Related]
9. Valvular heart disease associated with fenfluramine-phentermine.
Kurz X; Van Ermen A
N Engl J Med; 1997 Dec; 337(24):1772-3; author reply 1775. PubMed ID: 9411247
[No Abstract] [Full Text] [Related]
10. Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.
Ryan DH; Bray GA; Helmcke F; Sander G; Volaufova J; Greenway F; Subramaniam P; Glancy DL
Obes Res; 1999 Jul; 7(4):313-22. PubMed ID: 10440587
[TBL] [Abstract][Full Text] [Related]
11. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.
Follows OJ
Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755
[No Abstract] [Full Text] [Related]
12. Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity.
Wen PY; Feske SK; Teoh SK; Stieg PE
Neurology; 1997 Aug; 49(2):632-3. PubMed ID: 9270617
[No Abstract] [Full Text] [Related]
13. Diet pill psychosis.
Hoffman BF
Can Med Assoc J; 1977 Feb; 116(4):351-5. PubMed ID: 844014
[No Abstract] [Full Text] [Related]
14. Bipolar depression associated with fenfluramine and phentermine.
Zimmer JE; Gregory RJ
J Clin Psychiatry; 1998 Jul; 59(7):383-4. PubMed ID: 9714271
[No Abstract] [Full Text] [Related]
15. Fenfluramine and phentermine.
Howlin D
Ann Intern Med; 2001 Nov; 135(9):840-1. PubMed ID: 11694113
[No Abstract] [Full Text] [Related]
16. Diethylpropion hydrochloride: an effective appetite suppressant.
Bolding OT
Curr Ther Res Clin Exp; 1974 Jan; 16(1):40-8. PubMed ID: 4203847
[No Abstract] [Full Text] [Related]
17. [Pharmacological treatment of obesity. Drugs with predominantly anorectic action].
Ortensio A; Avagnina S; Costantino A
Minerva Dietol Gastroenterol; 1988; 34(2):109-16. PubMed ID: 3050610
[No Abstract] [Full Text] [Related]
18. Anorectic therapy and valvular heart disease: a reappraisal.
Silvestry FE; St John Sutton M
Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
[No Abstract] [Full Text] [Related]
19. Appetite-suppressant drugs and valvular heart disease.
Shapiro S
N Engl J Med; 1999 Feb; 340(6):477-8; author reply 478-80. PubMed ID: 9988622
[No Abstract] [Full Text] [Related]
20. After fen-phen.
Cowley G; Springen K
Newsweek; 1997 Sep; 130(13):46-8. PubMed ID: 10173270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
